OUTCOME OF NEUROBRUCELLOSIS FOCUSED ON TREATMENT
Journal Title: Acta Medica Balkanica - International Journal of Medical Sciences - Year 2019, Vol 4, Issue 7
Abstract
Background: This study aimed to analyze the outcome of neurobrucellosis according to treatment. Material/Methods: A cross-sectional epidemiologic survey was carried out in 648 patients with brucellosis hospitalized in Infectious Diseases Clinic, UCC of Kosova. Among them 82 patients fulfill criteria for neurobrucellosis and were analyzed regarding medication and outcome. Results: The mean age of patients with neurobrucellosis was 31.46 years, with age distribution 12-71 years. In this retrograde study the most often presentation of neurobrucellosis was affection of PNS in 34 (41, 46%), meningitis 28 (34.14%), and cranial nerve damages in 20 (24.39%). Radiculopathies of legs (41.46%) was leading finding followed by neck rigidity (46.34%). Clinically in admission patient present agitation (25,6%), behavioral disorders (18.3%) and disorientation (19.5%). Cranial nerves were involved in (24.4%). Five patients (6.1%) leave hospital with severe consequences, three patients with peripheral facial paresis, two with sensori-neural hearing loss and one with left hemiparesis. Leading complains for hospitalization improved in most patients after 6 weeks of treatment, which demonstrated a favorable efficacy. Cross-sectional epidemiologic survey suggested that sex and regional distribution were not related to nervous system damage (P>0.05), whereas duration of disease, prior to treatment, were related factor. From a totally 82 patients with neurobrucellosis, 43 patients are treated for 12 weeks, 34 for 24 weeks and 5 for 36 weeks. The shorter duration of treatment without relapses was 24 week. Conclusions: In endemic areas for brucellosis patients complaining in radiculopathies, persistent headache, facial palsy, hearing loss or presenting stroke without risk factors, should be considered for screening for neurobrucellosis. Based on our data, according to treatment and clinical follow-up, 24 weeks of antibiotic therapy in neurobrucellosis seems adequate. Duration of disease is risk factors for neurobrucellosis.
Authors and Affiliations
Shemsedin Dreshaj, Nexhmedin Shala, Gresa Dreshaj, Ekrem Ismani, Bujar Gjikolli
Keywords
Related Articles
- EP ID EP655607
- DOI -
- Views 203
- Downloads 0
EFFECTS OF STATINS IN THE TREATEMENT OF UREMIC DYSLIPIDEMIA
Cardiovascular disease further remains as the main cause of mortality in patients with kidney diseases . Uremic dysfunction and apolipoprotein metabolism disorders are counted as a wellknown risk factor of cardiovascular...
DIFFICULTIES IN THE LIBERALIZATION OF THE MARKET OF OTC MEDICATIONS IN REPUBLIC OF NORTH MACEDONIA AND EXPERIENCES FROM EUROPEAN COUNTRIES
Amendments to the Law on Medicines and Medical Devices (Official Gazette 27/2014) allow the marketing of OTC drugs outside pharmacies. Despite numerous controversies among the concerned parties, in February 2014, the Min...
VITAMIN D DEFICIENCY IN TETOVA REGION
Vitamin D is an essential nutrient needed to promote bone growth in children’s and adults. Normally vitamin D can be synthesized in the skin by exposure to sunlight, however during the winter and part of autumn is recomm...
HEALTHCARE PROFESSIONALS’ KNOWLEDGE, ATTITUDES AND PRACTICES TOWARDS PHARMACOVIGILANCE
Adverse drug reactions (ADRs) are known to be associated with morbidity and mortality and are one of the crucial problems associated with medicines. The aim of the Pharmacovigilance system is at sensitizing the healthcar...
STUDY ON THE IMPACT OF METFORMIN ON THE EFFECT OF PALM OIL IN THE METABOLISM OF CARBOHYDRATES
Introduction: Research has been published on the frequency of Metformin use in patients with various complications who have been using fat-rich foods. Our analysis of a large number of studies shows that: in parallel wit...